Terms: = Lung cancer AND TOP2A, TOP2, TP2A
117 results:
1. Exploring effective biomarkers and potential immune related gene in small cell lung cancer.
Yunchu Y; Miyanaga A; Matsuda K; Kamio K; Seike M
Sci Rep; 2024 Mar; 14(1):7604. PubMed ID: 38556560
[TBL] [Abstract] [Full Text] [Related]
2. Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma.
Yu Y; Li L; Luo B; Chen D; Yin C; Jian C; You Q; Wang J; Fang L; Cai D; Sun J
Biomed Pharmacother; 2024 May; 174():116528. PubMed ID: 38555814
[TBL] [Abstract] [Full Text] [Related]
3. Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironment.
Zhao X; Zhao R; Wen J; Zhang X; Wu S; Fang J; Ma J; Gao L; Hu Y
Med Oncol; 2024 Mar; 41(5):96. PubMed ID: 38526604
[TBL] [Abstract] [Full Text] [Related]
4. MDM2 provides top2 poison resistance by promoting proteolysis of top2βcc in a p53-independent manner.
Shu J; Jiang J; Wang X; Yang X; Zhao G; Cai T
Cell Death Dis; 2024 Jan; 15(1):83. PubMed ID: 38263255
[TBL] [Abstract] [Full Text] [Related]
5. cancer sensitizing effect of deazaflavin analogs is associated with increased intracellular drug accumulation.
Belhadj Z; Offei S; Jacobson BA; Cambron D; Kratzke RA; Wang Z; Xie J
Eur J Pharm Sci; 2024 Feb; 193():106686. PubMed ID: 38159687
[TBL] [Abstract] [Full Text] [Related]
6. Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell lung cancer Cell Line H1975.
Tong X; Zhang R; Sun R; Yang W; Sun J; Chen J; Li F
Anticancer Res; 2023 Dec; 43(12):5459-5474. PubMed ID: 38030186
[TBL] [Abstract] [Full Text] [Related]
7. Association of top2a and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma.
Yin D; Zhang Y; Li H; Cheng L
Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446
[TBL] [Abstract] [Full Text] [Related]
8. [Prognostic significance and immune cell infiltration analysis of differentially expressed genes in malignant pleural mesothelioma].
Wang N; Zhao QN; Yuan Q; Zhu BL; Wu W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Sep; 41(9):641-647. PubMed ID: 37805421
[No Abstract] [Full Text] [Related]
9. Non-small Cell lung cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-smokers.
Karlow JA; Pehrsson EC; Xing X; Watson M; Devarakonda S; Govindan R; Wang T
Genomics Proteomics Bioinformatics; 2023 Oct; 21(5):991-1013. PubMed ID: 37742993
[TBL] [Abstract] [Full Text] [Related]
10. mitoSplitter: A mitochondrial variants-based method for efficient demultiplexing of pooled single-cell RNA-seq.
Lin X; Chen Y; Lin L; Yin K; Cheng R; Lin X; Wang X; Guo Y; Wu Z; Zhang Y; Li J; Yang C; Song J
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2307722120. PubMed ID: 37725654
[TBL] [Abstract] [Full Text] [Related]
11. Identification of pivotal genes with prognostic evaluation value in lung adenocarcinoma by bioinformatics analysis.
Wang Y; Wang R; Ma J; Wang T; Ma C; Gu Y; Xu Y; Wang Y
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):221-225. PubMed ID: 37715381
[TBL] [Abstract] [Full Text] [Related]
12. The role of top2a in immunotherapy and vasculogenic mimicry in non-small cell lung cancer and its potential mechanism.
Wu J; Zhang L; Li W; Wang L; Jia Q; Shi F; Li K; Liao L; Shi Y; Wu S
Sci Rep; 2023 Jul; 13(1):10906. PubMed ID: 37407689
[TBL] [Abstract] [Full Text] [Related]
13. Glycolysis induces Th2 cell infiltration and significantly affects prognosis and immunotherapy response to lung adenocarcinoma.
Zeng L; Liang L; Fang X; Xiang S; Dai C; Zheng T; Li T; Feng Z
Funct Integr Genomics; 2023 Jul; 23(3):221. PubMed ID: 37400733
[TBL] [Abstract] [Full Text] [Related]
14. The clinicopathological significance of top2a expression in malignant peritoneal mesothelioma.
Du X; Li X; Zhang B; Hao Z; Gao Y; Jiang X; Yang Z; Chen Y
Ann Diagn Pathol; 2023 Aug; 65():152155. PubMed ID: 37172528
[TBL] [Abstract] [Full Text] [Related]
15. The potential bioactive ingredients and hub genes of five TCM prescriptions against lung adenocarcinoma were explored based on bioinformatics.
Liu T; Wei J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2039-2055. PubMed ID: 36914901
[TBL] [Abstract] [Full Text] [Related]
16. ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
Shu J; Wang X; Yang X; Zhao G
Sci Rep; 2023 Jan; 13(1):882. PubMed ID: 36650267
[TBL] [Abstract] [Full Text] [Related]
17. Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell lung cancer.
Liao R; Chen K; Li J; He H; Yi G; Huang M; Chen R; Shen L; Zhang X; Xu Z; Yang Z; Peng Y
Cancer Res Treat; 2023 Jul; 55(3):814-831. PubMed ID: 36634615
[TBL] [Abstract] [Full Text] [Related]
18. Diagnosis and Prognosis of Non-small Cell lung cancer based on Machine Learning Algorithms.
Zhou Y; Dong Y; Sun Q; Fang C
Comb Chem High Throughput Screen; 2023; 26(12):2170-2183. PubMed ID: 36627791
[TBL] [Abstract] [Full Text] [Related]
19. Verteporfin-loaded microparticles for radiosensitization of preclinical lung and breast metastatic spine cancer.
Akinduro OO; Suarez-Meade P; Roberts M; Tzeng SY; Sarabia-Estrada R; Schiapparelli P; Norton ES; Gokaslan ZL; Anastasiadis PZ; Guerrero-Cázares H; Green JJ; Quiñones-Hinojosa A
J Neurosurg Spine; 2023 Apr; 38(4):481-493. PubMed ID: 36585863
[TBL] [Abstract] [Full Text] [Related]
20. Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Wei RQ; Zhang WM; Liang Z; Piao C; Zhu G
Can Respir J; 2022; 2022():1394088. PubMed ID: 36072642
[TBL] [Abstract] [Full Text] [Related]
[Next]
